|
2025
|
Invention
|
Cyclic-amp response element binding protein (cbp) and/or adenoviral e1a binding protein of 300 kd... |
|
2024
|
Invention
|
Compounds and methods of treating cancers. Provided herein are heterobifunctional compounds of an... |
|
|
Invention
|
Tropomyosin receptor kinase (trk) degradation compounds and methods of use.
This disclosure rela... |
|
2023
|
Invention
|
Modified proteins and protein binders and degraders. Provided herein are compounds, pharmaceutica... |
|
|
Invention
|
Compounds and methods of treating cancers.
This disclosure relates to GSPT1 degrader compounds a... |
|
|
Invention
|
Compounds and methods of treating cancers. This disclosure relates to GSPT1 degrader compounds an... |
|
2022
|
Invention
|
Modified proteins and protein degraders.
Provided herein are compounds, pharmaceutical compositi... |
|
|
Invention
|
Modified proteins and protein degraders. Provided herein are compounds, pharmaceutical compositio... |
|
|
Invention
|
Compositions and methods of combination therapy for targeting lymphoma.
Provided are composition... |
|
|
Invention
|
Compositions and methods of combination therapy for targeting lymphoma. Provided are compositions... |
|
|
Invention
|
Tropomyosin receptor kinase (trk) degradation compounds and methods of use.
Heterobifunctional c... |
|
|
Invention
|
Modified proteins and protein binders.
Provided herein are compounds, pharmaceutical composition... |
|
|
Invention
|
Modified proteins and protein binders. Provided herein are compounds, pharmaceutical compositions... |
|
2021
|
Invention
|
Tyrosine kinase 2 (tyk2) degradation compounds and methods of use.
This disclosure relates to he... |
|
|
Invention
|
Tyrosine kinase 2 (tyk2) degradation compounds and methods of use. This disclosure relates to het... |
|
|
Invention
|
Compounds and methods of treating cancers.
This disclosure relates to GSPT1 degrader compounds (... |
|
|
Invention
|
Compounds and methods of treating cancers. This disclosure relates to GSPT1 degrader compounds (e... |
|
|
Invention
|
Compounds and methods of treating diseases. Provided are heterobifunctional compounds (e.g., bi-f... |
|
|
Invention
|
Tropomyosin receptor kinase (trk) degradation compounds and methods of use. This disclosure relat... |
|
2020
|
Invention
|
Compounds and methods of treating cancers.
This disclosure relates to heterobifunctional compoun... |
|
|
Invention
|
Compounds and methods of treating cancers. This disclosure relates to heterobifunctional compound... |
|
2019
|
Invention
|
Tropomyosin receptor kinase (trk) degradation compounds and methods of use. Bivalent compounds, c... |
